OVEREXPRESSION OF DOMINANT NEGATIVE TRANSFORMING GROWTH FACTOR (TGF)-β TYPE II RECEPTOR (DnTGFβRII) ATTENUATES PRESSURE OVERLOAD-INDUCED CARDIAC REMODELING AND DYSFUNCTION

被引:0
|
作者
Lucas, J. A. [1 ]
Miller, A. P. [1 ]
Zhang, Y. [1 ]
Li, P. [1 ]
Oparil, S. [1 ]
Chen, Y. [1 ]
机构
[1] Univ Alabama, Birmingham, AL USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:301 / 301
页数:1
相关论文
共 50 条
  • [21] Comparison of angiotensin II type 1-receptor blockers to regress pressure overload-induced cardiac hypertrophy in mice
    Lei Li
    Ning Zhou
    Hui Gong
    Jian Wu
    Li Lin
    Issei Komuro
    Junbo Ge
    Yunzeng Zou
    Hypertension Research, 2010, 33 : 1289 - 1297
  • [22] Microsatellite instability and transforming growth factor-beta receptor type II (TGF-beta RII) mutations in CTCL.
    Wood, GS
    Myeroff, L
    Markowitz, SD
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1997, 108 (04) : 371 - 371
  • [23] Fibroblast growth factor-inducible 14 mediates macrophage infiltration in heart to promote pressure overload-induced cardiac dysfunction
    Unudurthi, Sathya D.
    Nassal, Drew M.
    Patel, Nehal J.
    Thomas, Evelyn
    Yu, Jane
    Pierson, Curtis G.
    Bansal, Shyam S.
    Mohler, Peter J.
    Hund, Thomas J.
    LIFE SCIENCES, 2020, 247
  • [24] Dominant negative blockade of the transforming growth factor beta (TGF beta) type II receptor decreases breast cancer-mediated osteolysis.
    Yin, JJ
    Chirgwin, JM
    Taylor, SD
    Dallas, M
    Massague, J
    Mundy, GR
    Guise, TA
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : 180 - 180
  • [25] Cardiac specific expression of a dominant negative mutation in the natriuretic peptide a receptor exacerbates fibrotic and hypertrophic remodeling and diastolic dysfunction in response to pressure overload
    Patel, JB
    Valencik, ML
    Harders, GE
    Redfield, MM
    CIRCULATION, 2004, 110 (17) : 202 - 202
  • [26] Mineralocorticoid Receptor Deficiency in T Cells Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction Through Modulating T-Cell Activation
    Li, Chao
    Sun, Xue-Nan
    Zeng, Meng-Ru
    Zheng, Xiao-Jun
    Zhang, Yu-Yao
    Wan, Qiangyou
    Zhang, Wu-Chang
    Shi, Chaoji
    Du, Lin-Juan
    Ai, Tang-Jun
    Liu, Yuan
    Liu, Yan
    Du, Li-Li
    Yi, Yi
    Yu, Ying
    Duan, Sheng-Zhong
    HYPERTENSION, 2017, 70 (01) : 137 - 147
  • [27] Expression of a dominant-negative type II transforming growth factor beta (TGF-beta) receptor in the epidermis of transgenic mice blocks TGF-beta-mediated growth inhibition
    Wang, XJ
    Greenhalgh, DA
    Bickenbach, JR
    Jiang, AB
    Bundman, DS
    Krieg, T
    Derynck, R
    Roop, DR
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (06) : 2386 - 2391
  • [28] Down-regulation of transforming growth factor-β type II receptor (TGF-βRII) protein and mRNA expression in cervical cancer
    Jose Diaz-Chavez
    Rogelio Hernandez-Pando
    Paul F Lambert
    Patricio Gariglio
    Molecular Cancer, 7
  • [29] Down-regulation of transforming growth factor-β type II receptor (TGF-βRII) protein and mRNA expression in cervical cancer
    Diaz-Chavez, Jose
    Hernandez-Pando, Rogelio
    Lambert, Paul F.
    Gariglio, Patricio
    MOLECULAR CANCER, 2008, 7 (1)
  • [30] Transgenic mice with transforming growth factor β type II receptor dysfunction have attenuated hypoxia-induced pulmonary hypertension and remodeling.
    Feng, JA
    Li, P
    Xing, D
    Serra, R
    Oparil, S
    Chen, YF
    JOURNAL OF INVESTIGATIVE MEDICINE, 2005, 53 (01) : S327 - S327